Site Members can sign up for company wide alerts
Lawsuit Overview
January 18, 2022 - An investor in shares of NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) filed a lawsuit in the U.S. District Court for the District of Delaware over alleged violations of Federal Securities Laws by NRx Pharmaceuticals, Inc. in connection with certain allegedly false and misleading statements made between June 1, 2021 and November 4, 2021. Wilmington, DE based NRX Pharmace...
You must register (for free) or login to view the entire case.